当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:64.31亿  总市值:89.44亿
流通股本:3.35亿   总股本:4.66亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.20亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益508353.69万元,未分配利润190199.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产806234.52万元,负债297880.83万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入821,616,475.93,069,933,116.781,746,806,365.211,099,038,124.02
营业总成本694,874,920.332,690,140,421.731,466,821,630.31930,264,855.6
营业利润137,340,410.3373,167,958.91304,079,230.76189,079,930.86
利润总额135,432,168.8368,289,124.91302,288,879.01188,310,170.37
净利润120,104,766.3329,833,903.18264,182,740.83167,808,511.44
其他综合收益----
综合收益总额120,104,766.3329,833,903.18264,182,740.83167,808,511.44
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,725,458,129.663,648,969,542.583,348,371,664.993,074,979,408.23
非流动资产合计4,336,887,061.054,316,823,511.294,087,412,944.914,120,857,505.47
资产总计8,062,345,190.717,965,793,053.877,435,784,609.97,195,836,913.7
流动负债合计2,138,212,045.842,250,828,854.411,741,306,167.41,703,685,671.39
非流动负债合计840,596,233.41708,004,141.61736,630,765.67609,177,592.69
负债合计2,978,808,279.252,958,832,996.022,477,936,933.072,312,863,264.08
归属于母公司股东权益合计4,565,978,371.354,469,990,178.394,549,883,109.644,463,681,060.07
股东权益合计5,083,536,911.465,006,960,057.854,957,847,676.834,882,973,649.62
负债和股东权益合计8,062,345,190.717,965,793,053.877,435,784,609.97,195,836,913.7
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计990,540,979.934,095,851,891.511,778,174,197.981,173,987,012.83
经营活动现金流出小计917,009,839.793,360,305,684.361,422,050,640.26978,148,149.54
经营活动产生的现金流量净额73,531,140.14735,546,207.15356,123,557.72195,838,863.29
投资活动现金流入小计660,680,833.823,536,719,552.462,604,449,087.072,036,456,932.17
投资活动现金流出小计755,494,205.523,988,393,222.032,835,676,691.121,963,307,191.36
投资活动产生的现金流量净额-94,813,371.7-451,673,669.57-231,227,604.0573,149,740.81
筹资活动现金流入小计264,701,382.411,073,222,252.25713,050,000579,000,000
筹资活动现金流出小计269,165,519.111,206,500,773.91823,448,004.05790,957,215.44
筹资活动产生的现金流量净额-4,464,136.7-133,278,521.66-110,398,004.05-211,957,215.44
汇率变动对现金及现金等价物的影响163,359.08664,007.64392,159.94355,470.69
现金及现金等价物净增加额-25,583,009.18151,258,023.5614,890,109.5657,386,859.35
期末现金及现金等价物余额450,642,854.36476,225,863.54336,420,024.26378,916,774.05
最新报告期:2025-05-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券樊俊豪,熊承慧1.131.331.532025-05-26
民生证券徐菁1.061.171.272025-05-01
华泰证券季珂0.861.101.322025-04-30
中信证券盛夏,彭家乐0.911.081.372025-04-29
中金公司单妍,王思洋,龙友琪0.871.04--2025-04-28
TOP↑